Answers are grounded in this paper and cite their sources.
This research demonstrates selective hydrogenation of DMAPN to DMAPA using Ni-Cu catalysts, indicating a safer alternative to traditional methods.
N,N-Dimethyl-1,3-propanediamine (DMAPA) is an important aliphatic diamine widely used in fine chemical manufacturing. Its industrial production traditionally relies on Raney nickel catalysts, which suffer from pyrophoric hazards and limited selectivity due to imine condensation side reactions. To address these challenges, we report an Al2O3-supported Ni-Cu alloy catalyst as an efficient alternative for the selective hydrogenation of N,N-dimethylaminopropionitrile (DMAPN). The optimized Ni30Cu5/Al2O3 catalyst achieves complete DMAPN conversion and over 90% DMAPA selectivity under industrially relevant conditions (120 °C, 2.5 MPa H2). X-ray diffraction, X-ray photoelectron spectroscopy, and transmission electron microscopy analyses confirm the formation of substitutional Ni-Cu alloy nanoparticles, where Cu incorporation induces both geometric isolation of Ni ensembles and electronic modulation of surface active sites, thereby suppressing condensation-derived by-products. In addition, an NH3/ethanol-assisted process further improves selectivity while reducing autogenous operating pressure. Overall, this work demonstrates a safe and highly selective catalytic system for primary diamine synthesis, providing a practical alternative to conventional Raney Ni-based processes.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: